Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Thoracic Cancer
|
October 15, 2021
Trimodality therapy for esophageal cancer: The role of surgical and radiation treatment parameters in the development of anastomotic complications
Salem Alfaifi, Robert Chu, Xuan Hui, et al.
Plos One
|
May 10, 2007
Mutational analysis of EGFR and related signaling pathway genes in lung adenocarcinomas identifies a novel somatic kinase domain mutation in FGFR4
Jenifer L Marks, Michael D McLellan, Maureen F Zakowski, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 21, 2007
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
James Bean, Cameron Brennan, Jin-Yuan Shih, et al.
The New England Journal of Medicine
|
June 2, 2025
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer
Patrick M Forde, Jonathan D Spicer, Mariano Provencio, et al.
Cancers
|
November 9, 2024
Fecal Microbiome Composition Correlates with Pathologic Complete Response in Patients with Operable Esophageal Cancer Treated with Combined Chemoradiotherapy and Immunotherapy
Fyza Y Shaikh, Seoho Lee, James R White, et al.
Journal for Immunotherapy of Cancer
|
September 15, 2020
Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer
Joshua E Reuss, Valsamo Anagnostou, Tricia R Cottrell, et al.
Nature Medicine
|
March 20, 2024
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses
Ronan J Kelly, Blair V Landon, Ali H Zaidi, et al.
Journal for Immunotherapy of Cancer
|
November 17, 2020
Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee
Brian Gastman, Piyush K Agarwal, Adam Berger, et al.
The New England Journal of Medicine
|
April 17, 2018
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
Patrick M Forde, Jamie E Chaft, Kellie N Smith, et al.
Cardiovascular Engineering and Technology
|
September 12, 2018
Real-World Variability in the Prediction of Intracranial Aneurysm Wall Shear Stress: The 2015 International Aneurysm CFD Challenge
Kristian Valen-Sendstad, Aslak W Bergersen, Yuji Shimogonya, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Thoracic Cancer
|
October 15, 2021
Trimodality therapy for esophageal cancer: The role of surgical and radiation treatment parameters in the development of anastomotic complications
Salem Alfaifi, Robert Chu, Xuan Hui, et al.
Plos One
|
May 10, 2007
Mutational analysis of EGFR and related signaling pathway genes in lung adenocarcinomas identifies a novel somatic kinase domain mutation in FGFR4
Jenifer L Marks, Michael D McLellan, Maureen F Zakowski, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 21, 2007
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
James Bean, Cameron Brennan, Jin-Yuan Shih, et al.
The New England Journal of Medicine
|
June 2, 2025
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer
Patrick M Forde, Jonathan D Spicer, Mariano Provencio, et al.
Cancers
|
November 9, 2024
Fecal Microbiome Composition Correlates with Pathologic Complete Response in Patients with Operable Esophageal Cancer Treated with Combined Chemoradiotherapy and Immunotherapy
Fyza Y Shaikh, Seoho Lee, James R White, et al.
Journal for Immunotherapy of Cancer
|
September 15, 2020
Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer
Joshua E Reuss, Valsamo Anagnostou, Tricia R Cottrell, et al.
Nature Medicine
|
March 20, 2024
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses
Ronan J Kelly, Blair V Landon, Ali H Zaidi, et al.
Journal for Immunotherapy of Cancer
|
November 17, 2020
Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee
Brian Gastman, Piyush K Agarwal, Adam Berger, et al.
The New England Journal of Medicine
|
April 17, 2018
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
Patrick M Forde, Jamie E Chaft, Kellie N Smith, et al.
Cardiovascular Engineering and Technology
|
September 12, 2018
Real-World Variability in the Prediction of Intracranial Aneurysm Wall Shear Stress: The 2015 International Aneurysm CFD Challenge
Kristian Valen-Sendstad, Aslak W Bergersen, Yuji Shimogonya, et al.
Page
of 5